Showing results (41-50 of 214) with videos related to
Sort By:
Pageof 22
Clinical Pharmacology and Therapeutics|April 1, 1988
First-pass metabolism of imipramine and desipramine: impact of the sparteine oxidation phenotypeK Brøsen, L F GramClinical Pharmacology and Therapeutics|May 1, 1975
First-pass metabolism of imipramine in manL F Gram, J ChristiansenEuropean Journal of Clinical Pharmacology|January 1, 1989
Quinidine inhibits the 2-hydroxylation of imipramine and desipramine but not the demethylation of imipramineK Brøsen, L F GramEuropean Journal of Clinical Pharmacology|January 1, 1989
Clinical significance of the sparteine/debrisoquine oxidation polymorphismK Brøsen, L F GramEuropean Journal of Pharmacology|September 23, 1988
Effect of nifedipine on the shuttlebox escape deficit induced by inescapable shock in the ratM Geoffroy, E Mogilnicka, M Nielsen, et al.Neuropsychobiology|January 1, 1976
Cyclic AMP levels in cerebrospinal fluid in manic-melancholic patientsA Geisler, P Bech, M Johannesen, et al.Psychopharmacology Communications|January 1, 1975
Lithium research: does it lead to an integrative hypothesis for the manic-melancholic disorders?O J Rafaelsen, E T Mellerup, R W ShapiroPsychopathology|January 1, 1984
World Health Organization Schedule for Standardized Assessment of Depressive Disorders (WHO/SADD-5). Item combinations and interobserver reliabilityP Bech, A Gjerris, J Andersen, et al.Acta Psychiatrica Scandinavica|May 1, 1976
Fat cell number and weight gain in lithium treated patientsP B Vendsborg, N Bach-Mortensen, O J RafaelsenPharmacopsychiatry|January 1, 1986
Benzodiazepine suppression of cortisol secretion: a measure of anxiolytic activity?L F Gram, P ChristensenPageof 22